Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
37.92
+0.91 (2.46%)
Mar 17, 2026, 4:00 PM EDT - Market closed
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $2.04 billion as of March 17, 2026. Its market cap has increased by 231.61% in one year.
Market Cap
2.04B
Enterprise Value
1.79B
1-Year Change
231.61%
Ranking
Category
Stock Price
$37.92
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $2.04B, an increase of 212.02%. That is a compound annual growth rate of 28.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 1.99B | 42.08% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 2.15B |
| Zai Lab | 2.10B |
| Syndax Pharmaceuticals | 2.10B |
| Ultragenyx Pharmaceutical | 2.09B |
| Adaptive Biotechnologies | 2.06B |
| Mineralys Therapeutics | 2.06B |
| Oruka Therapeutics | 2.05B |
| Celldex Therapeutics | 1.97B |